Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-8.71x4.06x-0.23x3.85x-7.1x-6.67x-.--% 2.17B
17.24x1.96x-2.09x3.71x9.75x11.08x0.59% 66.75B
25.12x3.77x1.95x5.15x15.13x18.87x0.63% 50.65B
33.84x6.8x0.65x11.49x21.95x25.58x-.--% 42.55B
-46.25x2.52x0.36x3.25x9.6x11.2x3.32% 41.15B
33.28x1.52x-0.97x3.36x11.24x12.81x-.--% 28.34B
-7.78x4.72x-0.4x11.15x-6.85x-6.43x-.--% 26.76B
33.67x - -0.72x - - - -.--% 22.95B
62.3x5.76x0.38x6.33x43.55x42.67x-.--% 20B
-38.32x-6.71x0.91x17.89x-54.31x-56.78x-.--% 16.48B
25.21x3.54x0.02x5.21x13.96x19.24x-.--% 16.3B
-114.41x12460.81x2.59x12.23x-87.73x-120.46x-.--% 12.11B
16.65x - 0.17x3.55x13.02x15.6x-.--% 11.33B
51.14x20.85x0.48x30.87x43.66x45.03x0.18% 10.06B
44.79x - 4.15x - - - -.--% 10.01B
72.93x5.16x-0.94x - - - - 6.92B
30.13x - 1.48x8.14x21.59x25.78x0.34% 6.15B
11.62x1.01x0.4x1.79x7.22x9.68x2.89% 6.1B
-45.72x - -0.82x - - - - 5.76B
13.8x1.27x-0.2x2.39x6.2x7.51x1.63% 5.55B
Average 10.53x 834.47x 0.36x 8.15x 3.81x 3.42x 0.53% 20.4B
Weighted average by Cap. 11.80x 432.16x 0.12x 7.21x 7.74x 8.51x 0.6%
Biopharmaceuticals